R1 RCM Stock Price, News & Analysis (NASDAQ:RCM)

$5.17 0.00 (0.00 %)
(As of 02/25/2018 04:25 AM ET)
Previous Close$5.17
Today's Range$5.05 - $5.26
52-Week Range$2.02 - $5.43
Volume130,859 shs
Average Volume245,054 shs
Market Capitalization$542.85 million
P/E Ratio-19.88
Dividend YieldN/A
Beta-0.41

About R1 RCM (NASDAQ:RCM)

R1 RCM logoR1 RCM Inc. is a provider of revenue cycle management (RCM) and physician advisory services (PAS) to healthcare providers. The Company is engaged in providing management services of revenue cycle operations for the United States-based hospitals and other medical services providers. Its primary service offering consists of end-to-end RCM, which the Company deploys through a co-managed relationship or an operating partner relationship. The Company's PAS offering assists hospitals in complying with payer requirements regarding whether to classify a hospital visit as an in-patient or an out-patient observation case for billing purposes. The Company also provides customers with retrospective appeal management service support for both governmental and commercial payers. Its physicians conduct detailed retrospective reviews of medical records to identify medical necessity for hospital services and the required documentation to support an appeal.

Receive RCM News and Ratings via Email

Sign-up to receive the latest news and ratings for RCM and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Ambulance & Emergency Services
Sub-IndustryHealth Care Services
SectorFinance
SymbolNASDAQ:RCM
CUSIP00438V10
Phone312-324-7820

Debt

Debt-to-Equity RatioN/A
Current Ratio2.53%
Quick Ratio2.53%

Price-To-Earnings

Trailing P/E Ratio-19.8846153846154
Forward P/E Ratio-43.08
P/E GrowthN/A

Sales & Book Value

Annual Sales$592.56 million
Price / Sales0.92
Cash Flow$1.75 per share
Price / Cash2.95
Book Value($0.12) per share
Price / Book-43.08

Profitability

Trailing EPS($0.26)
Net Income$177.07 million
Net Margins-1.32%
Return on Equity-9.33%
Return on Assets-1.50%

Miscellaneous

Employees6,644
Outstanding Shares105,000,000

R1 RCM (NASDAQ:RCM) Frequently Asked Questions

What is R1 RCM's stock symbol?

R1 RCM trades on the NASDAQ under the ticker symbol "RCM."

How were R1 RCM's earnings last quarter?

R1 RCM Inc (NASDAQ:RCM) posted its earnings results on Tuesday, May, 10th. The financial services provider reported $0.85 EPS for the quarter, topping the Zacks' consensus estimate of ($0.04) by $0.89. The financial services provider had revenue of $352.19 million for the quarter, compared to analysts' expectations of $56.70 million. R1 RCM had a negative return on equity of 9.33% and a negative net margin of 1.32%. View R1 RCM's Earnings History.

When will R1 RCM make its next earnings announcement?

R1 RCM is scheduled to release their next quarterly earnings announcement on Wednesday, March, 7th 2018. View Earnings Estimates for R1 RCM.

Where is R1 RCM's stock going? Where will R1 RCM's stock price be in 2018?

1 analysts have issued twelve-month price objectives for R1 RCM's shares. Their forecasts range from $5.00 to $5.00. On average, they expect R1 RCM's share price to reach $5.00 in the next twelve months. View Analyst Ratings for R1 RCM.

Who are some of R1 RCM's key competitors?

Who are R1 RCM's key executives?

R1 RCM's management team includes the folowing people:

  • Steven J. Shulman, Chairman of the Board , Independent Director (Age 65)
  • Joseph Gerard Flanagan, President, Chief Executive Officer, Director (Age 45)
  • Christopher Simon Ricaurte, Chief Financial Officer, Treasurer (Age 57)
  • Thomas A. Lesica, Chief Operating Officer, Executive Vice President (Age 57)
  • Gary Steven Long, Executive Vice President, Chief Commercial Officer
  • Michael C. Feiner, Director (Age 74)
  • John Bell Henneman III, Director (Age 55)
  • Joseph R. Impicciche, Director (Age 59)
  • Neal Moszkowski, Director (Age 51)
  • Ian R. Sacks, Director (Age 46)

Who owns R1 RCM stock?

R1 RCM's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Paradigm Capital Management Inc. NY (6.53%), BlackRock Inc. (4.60%), Eversept Partners LLC (1.56%), SLS Management LLC (1.27%), Balter Liquid Alternatives LLC (0.54%) and Tamarack Advisers LP (0.38%). Company insiders that own R1 RCM stock include Alex Mandl, John B Henneman III and Joseph Gerard Flanagan. View Institutional Ownership Trends for R1 RCM.

Who sold R1 RCM stock? Who is selling R1 RCM stock?

R1 RCM's stock was sold by a variety of institutional investors in the last quarter, including Paradigm Capital Management Inc. NY, Continental Advisors LLC, Metropolitan Life Insurance Co. NY, Renaissance Technologies LLC, Tamarack Advisers LP, Rhumbline Advisers and TIAA CREF Investment Management LLC. View Insider Buying and Selling for R1 RCM.

Who bought R1 RCM stock? Who is buying R1 RCM stock?

R1 RCM's stock was acquired by a variety of institutional investors in the last quarter, including Eversept Partners LLC, Gilder Gagnon Howe & Co. LLC, Fairpointe Capital LLC, Balter Liquid Alternatives LLC, Wells Fargo & Company MN, Two Sigma Investments LP, SLS Management LLC and Deutsche Bank AG. Company insiders that have bought R1 RCM stock in the last two years include Alex Mandl, John B Henneman III and Joseph Gerard Flanagan. View Insider Buying and Selling for R1 RCM.

How do I buy R1 RCM stock?

Shares of R1 RCM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is R1 RCM's stock price today?

One share of R1 RCM stock can currently be purchased for approximately $5.17.

How big of a company is R1 RCM?

R1 RCM has a market capitalization of $542.85 million and generates $592.56 million in revenue each year. The financial services provider earns $177.07 million in net income (profit) each year or ($0.26) on an earnings per share basis. R1 RCM employs 6,644 workers across the globe.

How can I contact R1 RCM?

R1 RCM's mailing address is 401 NORTH MICHIGAN AVENUE SUITE 2700, CHICAGO IL, 60611. The financial services provider can be reached via phone at 312-324-7820 or via email at [email protected]


MarketBeat Community Rating for R1 RCM (RCM)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  95 (Vote Outperform)
Underperform Votes:  109 (Vote Underperform)
Total Votes:  204
MarketBeat's community ratings are surveys of what our community members think about R1 RCM and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

R1 RCM (NASDAQ:RCM) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.002.002.002.00
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $5.00$5.00$5.00$5.00
Price Target Upside: 44.72% upside44.72% upside44.72% upside54.80% upside

R1 RCM (NASDAQ:RCM) Consensus Price Target History

Price Target History for R1 RCM (NASDAQ:RCM)

R1 RCM (NASDAQ:RCM) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
9/26/2017Robert W. BairdReiterated RatingHold$5.00HighView Rating Details
(Data available from 2/25/2016 forward)

Earnings

R1 RCM (NASDAQ:RCM) Earnings History and Estimates Chart

Earnings by Quarter for R1 RCM (NASDAQ:RCM)

R1 RCM (NASDAQ RCM) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/7/2018        
10/31/2017Q3 2017($0.03)($0.08)$109.80 million$123.20 millionViewN/AView Earnings Details
8/2/2017Q2 2017($0.04)($0.11)$91.95 million$99.40 millionViewListenView Earnings Details
5/9/2017Q1 2017($0.04)($0.12)$74.10 million$86.90 millionViewListenView Earnings Details
3/1/2017Q4 2016($0.03)$0.05$67.10 million$106.16 millionViewN/AView Earnings Details
11/2/2016Q3 2016$0.18$48.10 million$125.54 millionViewN/AView Earnings Details
8/4/2016Q2 2016($0.08)($0.45)$43.50 million$8.67 millionViewN/AView Earnings Details
5/10/2016Q1($0.04)$0.85$56.70 million$352.19 millionViewListenView Earnings Details
3/10/2016Q4$0.08$0.06$68.90 million$68.34 millionViewListenView Earnings Details
11/9/2015Q315$0.05($0.34)$60.39 million$15.80 millionViewListenView Earnings Details
8/5/2015Q215$0.02($0.27)$56.51 million$22.09 millionViewListenView Earnings Details
7/7/2015Q1 2015($0.32)$53.00 million$10.97 millionViewN/AView Earnings Details
6/23/2015($0.13)$0.19$12.96 millionViewListenView Earnings Details
11/7/2012Q312$0.05$0.06$231.06 million$223.10 millionViewN/AView Earnings Details
8/8/2012$0.08$0.03ViewN/AView Earnings Details
5/9/2012$0.06$0.06ViewN/AView Earnings Details
2/29/2012$0.16$0.17ViewN/AView Earnings Details
11/9/2011$0.12$0.11ViewN/AView Earnings Details
8/10/2011Q2 2011$0.07$0.08ViewN/AView Earnings Details
5/11/2011$0.04$0.04ViewN/AView Earnings Details
3/2/2011$0.09$0.09ViewN/AView Earnings Details
11/11/2010Q3 2010$0.03$0.03ViewN/AView Earnings Details
8/12/2010Q2 2010$0.04$0.04ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

R1 RCM (NASDAQ:RCM) Earnings Estimates

Current Year EPS Consensus Estimate: $-0.12 EPS
Next Year EPS Consensus Estimate: $-0.04 EPS

Dividends

Dividend History for R1 RCM (NASDAQ:RCM)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

R1 RCM (NASDAQ RCM) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 62.00%
Institutional Ownership Percentage: 41.71%
Insider Trades by Quarter for R1 RCM (NASDAQ:RCM)
Insider Trades by Quarter for R1 RCM (NASDAQ:RCM)

R1 RCM (NASDAQ RCM) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/16/2016John B Henneman IIIDirectorBuy50,000$1.80$90,000.00100View SEC Filing  
8/11/2016Alex MandlDirectorBuy200,000$1.59$318,000.0065,700View SEC Filing  
8/10/2016Joseph Gerard FlanaganCEOBuy100,000$1.56$156,000.001,431,814View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

R1 RCM (NASDAQ RCM) News Headlines

Source:
DateHeadline
Form 4 R1 RCM INC. For: Feb 16 Filed by: FLANAGAN JOSEPH GERARDForm 4 R1 RCM INC. For: Feb 16 Filed by: FLANAGAN JOSEPH GERARD
www.streetinsider.com - February 17 at 9:11 AM
Presence Health Selects R1 RCM for End-to-End Revenue Cycle ManagementPresence Health Selects R1 RCM for End-to-End Revenue Cycle Management
finance.yahoo.com - February 16 at 9:20 AM
Brokerages Expect R1 RCM Inc (RCM) to Announce $0.02 Earnings Per ShareBrokerages Expect R1 RCM Inc (RCM) to Announce $0.02 Earnings Per Share
www.americanbankingnews.com - February 13 at 9:08 AM
R1 RCM (RCM) Raised to "Buy" at BidaskClubR1 RCM (RCM) Raised to "Buy" at BidaskClub
www.americanbankingnews.com - January 27 at 12:52 AM
Intermountain Healthcare Selects R1 for Integrated, Enterprise-wide Revenue CycleIntermountain Healthcare Selects R1 for Integrated, Enterprise-wide Revenue Cycle
finance.yahoo.com - January 24 at 9:22 AM
R1 RCM (RCM) Rating Lowered to Hold at BidaskClubR1 RCM (RCM) Rating Lowered to Hold at BidaskClub
www.americanbankingnews.com - January 21 at 1:34 PM
Zacks Investment Research Downgrades R1 RCM (RCM) to SellZacks Investment Research Downgrades R1 RCM (RCM) to Sell
www.americanbankingnews.com - January 17 at 12:44 PM
R1 RCM (RCM) Upgraded at BidaskClubR1 RCM (RCM) Upgraded at BidaskClub
www.americanbankingnews.com - January 14 at 10:30 PM
 R1 RCM Inc (RCM) Given $5.00 Average Price Target by Brokerages R1 RCM Inc (RCM) Given $5.00 Average Price Target by Brokerages
www.americanbankingnews.com - January 12 at 3:16 AM
R1 RCM (RCM) Downgraded by BidaskClub to BuyR1 RCM (RCM) Downgraded by BidaskClub to Buy
www.americanbankingnews.com - January 5 at 10:20 PM
BRIEF-TCP-ASC ACHI Series LLLP - Exploring With R1 RCM Inc Possible Provision Of Debt, Equity Financing In Connection With Potential Acquisition By CoBRIEF-TCP-ASC ACHI Series LLLP - Exploring With R1 RCM Inc Possible Provision Of Debt, Equity Financing In Connection With Potential Acquisition By Co
www.reuters.com - January 4 at 4:16 PM
BidaskClub Upgrades R1 RCM (RCM) to "Strong-Buy"BidaskClub Upgrades R1 RCM (RCM) to "Strong-Buy"
www.americanbankingnews.com - December 27 at 11:48 AM
 R1 RCM Inc (RCM) Receives Average Rating of "Buy" from Brokerages R1 RCM Inc (RCM) Receives Average Rating of "Buy" from Brokerages
www.americanbankingnews.com - December 25 at 11:40 AM
R1 RCM to Present at the 36th Annual J.P. Morgan Healthcare ConferenceR1 RCM to Present at the 36th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - December 20 at 10:42 AM
Analysts Anticipate R1 RCM Inc (RCM) to Announce $0.01 EPSAnalysts Anticipate R1 RCM Inc (RCM) to Announce $0.01 EPS
www.americanbankingnews.com - December 20 at 3:22 AM
ETFs with exposure to R1 RCM, Inc. : December 12, 2017ETFs with exposure to R1 RCM, Inc. : December 12, 2017
finance.yahoo.com - December 12 at 4:13 PM
Critical Comparison: Examworks Group (EXAM) and R1 RCM (RCM)Critical Comparison: Examworks Group (EXAM) and R1 RCM (RCM)
www.americanbankingnews.com - December 9 at 8:04 AM
LHC Group (LHCG) versus Accretive Health (RCM) Head to Head ContrastLHC Group (LHCG) versus Accretive Health (RCM) Head to Head Contrast
www.americanbankingnews.com - December 7 at 1:16 PM
Head to Head Comparison: LHC Group (LHCG) versus Accretive Health (RCM)Head to Head Comparison: LHC Group (LHCG) versus Accretive Health (RCM)
www.americanbankingnews.com - December 4 at 9:34 PM
Critical Survey: Accretive Health (RCM) vs. Examworks Group (EXAM)Critical Survey: Accretive Health (RCM) vs. Examworks Group (EXAM)
www.americanbankingnews.com - December 2 at 11:54 AM
Accretive Health (RCM) & Examworks Group (EXAM) Head-To-Head ComparisonAccretive Health (RCM) & Examworks Group (EXAM) Head-To-Head Comparison
www.americanbankingnews.com - November 27 at 10:10 AM
Critical Comparison: LHC Group (LHCG) vs. Accretive Health (RCM)Critical Comparison: LHC Group (LHCG) vs. Accretive Health (RCM)
www.americanbankingnews.com - November 25 at 1:48 AM
Accretive Health (RCM) versus Examworks Group (EXAM) Head-To-Head AnalysisAccretive Health (RCM) versus Examworks Group (EXAM) Head-To-Head Analysis
www.americanbankingnews.com - November 25 at 1:24 AM
Comparing LHC Group (LHCG) and Accretive Health (RCM)Comparing LHC Group (LHCG) and Accretive Health (RCM)
www.americanbankingnews.com - November 25 at 1:22 AM
ETFs with exposure to R1 RCM, Inc. : November 24, 2017ETFs with exposure to R1 RCM, Inc. : November 24, 2017
finance.yahoo.com - November 24 at 5:51 PM
Financial Review: LHC Group (LHCG) versus Accretive Health (RCM)Financial Review: LHC Group (LHCG) versus Accretive Health (RCM)
www.americanbankingnews.com - November 22 at 8:04 AM
Financial Review: LHC Group (LHCG) & Accretive Health (RCM)Financial Review: LHC Group (LHCG) & Accretive Health (RCM)
www.americanbankingnews.com - November 20 at 11:19 AM

SEC Filings

R1 RCM (NASDAQ:RCM) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

R1 RCM (NASDAQ:RCM) Income Statement, Balance Sheet and Cash Flow Statement

Chart

R1 RCM (NASDAQ RCM) Stock Chart for Sunday, February, 25, 2018

Loading chart…

This page was last updated on 2/25/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.